Beat estimates on rev by $1 million and (earnings) by 1 cent/share. I think that their new product is gaining traction quickly and the announcement of expansion into Canada is also good news. This is a buy and hold co.
Yes, they seem to getting closer to profitability, but not quite there yet. The company has had FDA approval for 7+ years, but becoming profitable has been like turning around a battleship in a bathtub. The new features of the system and the changing business model have consumed some of their cash, but it should pay off in the long run. Hopefully not too much longer though! They stopped predicting breakeven or profitability many quarters ago, and they don't seem to be in a hurry to get there. 'Breaking even' financially will probably be the next catalyst that will drive the stock price. As long as they don't run out of cash before then, I'll hang in there.